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SPONTANEOUS PNEUMOMEDIASTINUM IN PATIENTS
WITH COVID-19. CASE REPORT
NEUMOMEDIASTINO ESPONTÁNEO EN UN PACIENTE CON COVID-19. REPORTE DE CASO
Pedro Paolo Sotelo-Jiménez1,a, Enrique Moyano-Navarro1,a, Félix Tipacti-Rodríguez2,a, Carlos Milla-Bravo3,c

ABSTRACT

CLINICAL CASE

Introduction: Pneumomediastinum is an infrequent and rare pathology. The typical radiological
manifestations in patients with SARS-CoV-2 pneumonia consist of the presence of bilateral pulmonary
opacities, of peripheral distribution. In a recent series of patients with COVID-19, it indicates that 1%
of patients can develop spontaneous pneumomediastinum as a complication, it is generally benign
and it is not yet clear that this may be an indicator of worsening. Clinical Case: This is a 43-year-old
male patient who presented a 15-day illness characterized by pharyngeal pain, fever, chest pain and
respiratory distress, receiving multiple antiviral and antibiotic treatment schemes without response, for
which he attended to Rebagliati Hospital where he was found respiratory failure, hypoxemia and sepsis.
His tomography was compatible with ground glass infiltrate, areas of bilateral lung consolidation, and
pneumomediastinum. It did not require surgical treatment and it evolved favorably to pneumonia with
a decrease in inflammatory markers and remission of pneumomediastinum in tomographic control.
Conclusion: This report highlights that in COVID-19 infection the pulmonary complications to take into
account are bilateral pneumonia, bacterial coinfection, sepsis and spontaneous pneumomediastinum.
Key words: Spontaneous Pneumomediastinum; COVID-19; Case Report (source: MeSH NLM).

RESUMEN
Introducción: El neumomediastino es una patología poco frecuente y rara. Las manifestaciones
radiológicas típicas en los pacientes en neumonía por SARS-CoV-2 consiste en la presencia de
opacidades pulmonares bilaterales, de distribución periférica. En una reciente serie de pacientes con
COVID-19 indica que el 1% de los pacientes pueden desarrollar neumomediastino espontáneo como
complicación, generalmente es de curso benigno y no se aclara aún que ello puede suponer un indicador
de agravamiento. Caso Clínico: Se trata de un paciente varón de 43 años que presentó un tiempo de
enfermedad de 15 días caracterizado por dolor faríngeo, fiebre, dolor torácico y dificultad respiratoria,
recibiendo múltiples esquemas de tratamiento tanto antiviral y antibióticos sin respuesta, por lo que
acudió al Hospital Rebagliati donde se le encontró insuficiencia respiratoria, hipoxemia y sepsis. Su
tomografía fue compatible con infiltrado en vidrio deslustrado, áreas de consolidación pulmonar bilateral
y neumomediastino. No requirió tratamiento quirúrgico y evolucionó favorablemente a la neumonía
con disminución de marcadores inflamatorios y remisión de neumomediastino en control tomográfico.
Conclusión: Este reporte resalta que en la infección por COVID-19 las complicaciones pulmonares a tener
en cuenta son la neumonía bilateral, coinfección bacteriana, sepsis y neumomediastino espontáneo.
Palabras clave: Spontaneous Pneumomediastinum; COVID-19; Reporte de Caso (fuente: DeCS BIREME).
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INTRODUCTION

CLINICAL CASE

Spontaneous pneumomediastinum (SPM) or
Hamman's syndrome is a secondary complication
to increased intra-alveolar pressure that causes
alveolar rupture and air outflow from the bronchial
tree to the mediastinum(1), which in turn can spread
to the subcutaneous tissue, exceptionally at the
endothoracic and peritoneal levels, or even to the
spinal canal(1,2).
It was first described in 1939 as a very characteristic
but infrequent sign consisting of crepitus
concomitant with the heartbeat and is perceived
during auscultation of the anterior thoracic region
(Hamman's sign)(3). The predisposing conditions
which have been described are interstitial pulmonary
and chronic obstructive diseases, bronchial asthma,
bronchiectasis, trauma and thoracic procedures,
mechanical ventilation, inhaling toxic substances,
foreign body, chesty cough, labor and lung cancer.
The probability to develop such pathology is a
consequence of respiratory infections with severe
cough as it is in the case of infection by coronavirus
SARS-CoV-2(2,4).

CLINICAL CASE
A 43-year-old male patient from Lima with a history
of overweight. He denied tobacco use and previous
pulmonary diseases. He was in direct epidemiological
contact five days prior with his brother who had
been infected by coronavirus. He presented a
15-day illness characterized by pharyngeal pain,
general discomfort, moderate frontoparietal
cephalea, fever, anosmia and ageusia. He received
ambulatory treatment with multiple schemes:
clarithromycin, hydroxychloroquine, ivermectin,
levofloxacin (stopped due to allergic reaction) and
intravenous ceftriaxone without clinical response
until he developed chest pain, lingering cough
with greenish sputum and progressive respiratory
distress four days prior to hospital admission. Due
to this, he attended the emergency department
at CELIM - Hospital Nacional Edgardo Rebagliati
Martins (HNERM) reaching oxygen saturation (Sat02)
at 86%. It was initially diagnosed as acute respiratory
failure and atypical pneumonia caused by COVID-19
requiring oxygen therapy by mask with a reservoir
bag. There was no history of invasive procedures in
the thoracic area.
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Physical assessment: Blood pressure: 100/60 mmHg,
Heart rate: 110 heartbeats per minute, Respiratory
rate: 28 breaths per minute, receiving 15 liters of
oxygen per minute (Oxygen saturation: 93%), in poor
general conditions, supraclavicular subcutaneous
emphysema and erythematous papular lesions on
the back and shoulders were palpated.
Thorax: decreased vesicular murmur and crepitus in
both lung bases.
Ancillary testing at the time of admission showed:
leukocytes: 20,130; lymphocytes: 840; hemoglobin:
13.3 g
/dl; platelets: 1049,000; glucose: 87mg/
dl; creatinine: 1.09 mg/dl; fibrinogen: 976mg/dl;
D-Dimer: 0.46 ug/ml; CPK MB: 0.59; Troponin: 0.008;
LDH: 402 U/L; CRP: 14.47 ng/ml; Ferritin: 1663 ng/ml.
PaFiO2: 102. Lactate:1,2. lgM Rapid Test, Molecular
PCR test positive for SARS-CoV-2.
Blood cultures for common germs were negative for
bacterial growth.
The chest tomography scan showed areas
of alveolar infiltrate in frosted glass, bilateral
consolidation with 50% pulmonary compromise,
as well as subcutaneous emphysema and
pneumomediastinum (Figure 1 and 2).
Upon medical assessment by the Thoracic Surgery
Department, it was concluded he did not require a
special surgical procedure and only conservative
management and observation was needed.
He was given 250 mg of methylprednisolone
every 24 hours for 5 days, 60 mg of enoxaparin
subcutaneously every 24 hours, 4.5 g of piperacillin/
tazobactam intravenously every 6 hours for 10 days,
progressive weaning of oxygen therapy and strict
monitoring of oxygen saturation.
He progressed favorably and his medical controls
two weeks after showed gas disappearance in soft
tissues at cervical and mediastinum levels, bilateral
evolutive consolidations (Figure 3A and 3B).
Analytics of improvement: hemogram with with
8726 leukocytes, 1700 lymphocytes, Hb 12 g/dl;
300,000 platelets; LDH 204 ng/ml; CRP <0.4 U/L;
ferritin: 593 ng/ml.
He was discharged 18 days after, hemodynamically
stable, no fever, with oxygen saturation at 97% and
no use of supplemental oxygen.
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CLINICAL CASE

Figure 1. 1A: chest x-ray showing bilateral pulmonary infiltrates and gas in subcutaneous tissue at cervical
level. 1B: chest tomography scan showing subcutaneous cervical emphysema.

Figure 2. 2A: chest tomography scan showing dissection of subcutaneous emphysema at thoracic and
axillary levels, pneumomediastinum and bilateral ground-glass images. 2B: chest tomography scan showing
pneumomediastinum, bullae, ground-glass areas and marked consolidation at the lung bases.

3A

3B

Figure 3. 3A: chest tomography scan showing remission of pneumomediastinum and a 15-days
subcutaneous emphysema. 3B: chest tomography scan showing evolving pulmonary consolidations with
some fibrous tracts.
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DISCUSIÓN

CLINICAL CASE

Pneumomediastinum is an infrequent and rare
pathology with an incidence of 1:44000 hospital
admissions. It is over 70% more frequent in young
males, generally originating from air migration
from the ruptured alveoli to the mediastinum
through the Macklin effect6. The typical radiological
manifestations in patients with SARS-CoV-2
pneumonia consist of the presence of bilateral
ground-glass pulmonary opacities, peripheral
distribution, consolidations and pulmonary
thromboembolism in some cases5.
In this case, our patient used several drugs
(antimicrobials) on an outpatient basis with no
proven efficacy at the present time. According to a
meta-analysis, only 3.5% of patients present bacterial
co-infection at the time of admission while 15%
of them present it during hospital stay, and more
than 71% were prescribed antibiotics, all of which
generates bacterial resistance, adverse reactions and
unnecessary costs7 as a consequence.
A recent series of patients with COVID-19 indicates
that 1% of patients can develop spontaneous
pneumomediastinum
as
a
complication(8)
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and, although the exact mechanism by which
spontaneous pneumomediastinum occurs in SARSCoV-2 pneumonia is unknown, it is attributed
to intense coughing or valsalva maneuvers. In
theory, it is considered a self-limited and benign
condition which responds favorably to conservative
therapeutic measures in most cases(7), but it requires
observation and continuous follow-up when there
is a predisposing pulmonary disease due to the
possibility of related cardiovascular and respiratory
complications. Therefore, further research is needed
to determine its prognostic significance and, in
case it becomes a marker of disease progression
in COVID-19 infection, measures or specific
recommendations(4,7) should be established.

CONCLUSION
This case report stresses the pulmonary
complications to be considered in patients
infected by COVID-19, such as bilateral pneumonia,
bacterial coinfection, sepsis, respiratory failure and
spontaneous pneumomediastinum. The treatment
for this last mentioned is observation and continuous
monitoring, especially in patients who show disease
progression.
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